Spiro-substituted pyrrolopyrimidines

Details for Australian Patent Application No. 2004215648 (hide)

Owner Novartis AG

Inventors Miyake, Takahiro; Iwasaki, Genji; Teno, Naoki; Irie, Osamu; Masuya, Keiichi

Agent Davies Collison Cave

Pub. Number AU-B-2004215648

PCT Pub. Number WO2004/076455

Priority 0304640.6 28.02.03 GB

Filing date 27 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 11 October 2007

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076455 Priority application(s): WO2004/076455

11 October 2007 Application Accepted

  Published as AU-B-2004215648

7 February 2008 Standard Patent Sealed

23 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215653-Antibody purification by protein A and ion exchange chromatography

2004215647-Process for preparing 5-[(R)-2-(5,6-diethyl-indian-2-ylamino)-1 -hydroxyethyl)-8-hydroxy-(1H)-quinolin-2-one salt, useful as an adrenoceptor agonist